Multiple Sclerosis Risk Factors
This is a U.S. news story, published by Yahoo, that relates primarily to Evelo Biosciences news.
U.S. news
For more U.S. news, you can click here:
more U.S. newsEvelo Biosciences news
For more Evelo Biosciences news, you can click here:
more Evelo Biosciences newsdisease research news
For more disease research news, you can click here:
more disease research newsYahoo news
For more news from Yahoo, you can click here:
more news from YahooAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like disease research news, you might also like this article about
multiple sclerosis lack gut bacteria. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest multiple sclerosis patients news, multiple sclerosis severity news, disease research news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Multiple sclerosisThe Conversation
•Health
Health
Out-of-balance bacteria is linked to multiple sclerosis − the ratio can predict severity of disease
89% Informative
Multiple sclerosis affects nearly one million people in the U.S. and over 2.8 million worldwide.
Scientists have long suspected that gut bacteria may influence a person’s risk of developing multiple sclerosis.
The ratio of two bacteria in the gut can predict multiple sclerosis severity in patients.
Ashutosh Mangalam: These findings offer a promising new direction for understanding and treating multiple sclerosis.
Mangalam received funding from the NIH / NIAID , VA and the University of Iowa .
He holds a patent licensed to Evelo Biosciences by Mayo Clinic on a technology using Prevotella histicola to treat autoimmune diseases.
VR Score
93
Informative language
94
Neutral language
49
Article tone
informal
Language
English
Language complexity
71
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
20
Affiliate links
no affiliate links